thymidine 5'-triphosphate has been researched along with Minimal Disease, Residual in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brabender, J; Hoelscher, AH; Hoffmann, AC; Ling, F; Lurje, G; Metzger, R; Schneider, PM; Vallböhmer, D; Warnecke-Eberz, U | 1 |
1 other study(ies) available for thymidine 5'-triphosphate and Minimal Disease, Residual
| Article | Year |
|---|---|
Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dihydrouracil Dehydrogenase (NADP); Feasibility Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Postoperative Period; Radiotherapy, Adjuvant; Rectal Neoplasms; Regression Analysis; RNA, Messenger; ROC Curve; Sensitivity and Specificity; Survival Rate; Thymine Nucleotides | 2009 |